Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation.
Ontology highlight
ABSTRACT: Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhib
SUBMITTER: Tuohetahuntila M
PROVIDER: S-EPMC5535019 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA